Trial Results

July 7, 2021
TMIST recruitment graph

Trial Updates: TMIST Enrollment Hits 50,000; NCI-MATCH News; Recent Research Results

Recent ECOG-ACRIN trial updates and results
May 28, 2021
Female doctor on laptop

ECOG-ACRIN and PrECOG Research at ASCO 2021

Researchers with the ECOG-ACRIN Cancer Research Group and PrECOG, LLC will present a wide range of research findings at the 2021 ASCO Annual Meeting
January 25, 2021
Pink Rubik's cube

Joe Sparano: Refining Individual Risk in Breast Cancer

Dr. Sparano discusses the scientific and statistical collaboration behind a new tool, RSClin™, which integrates clinical–pathological and genomic risk information to guide adjuvant chemotherapy in node-negative breast cancer
October 19, 2020

Trial Results: Genomic study of 6000 NCI-MATCH cancer patients leads to new clinical trial benchmarks

The Journal of Clinical Oncology published new data from the NCI-MATCH precision medicine cancer trial that has broad relevance in medicine and provides a roadmap for future precision medicine trials
September 14, 2020
PrECOG logo

Trial Results: PALbociclib CoLlaborative Adjuvant Study (PALLAS)

A second interim analysis of this international adjuvant study for HR+, HER2- early breast cancer demonstrates that there is little chance of palbociclib reducing the risk of recurrence
July 29, 2020

Trial Results: E3311 Leads to Phase III Trial in Head and Neck Cancer

Learn more about a less intense treatment that preserves throat function and spares unnecessary toxicities
June 10, 2020
E2112 video image

Trial Results: E2112 Finds No Significant Overall Survival Benefit With Entinostat/Exemestane in Advanced Breast Cancer

The study results, as well as correlative analyses, will be reported in an upcoming medical meeting
April 15, 2020
Brain fog image

Trial Results: TAILORx Cognition Data in JCO and EA1141 Brief MRI vs 3-D in JAMA

February 28, 2020
News in Brief

News in Brief, February 2020